Functions and applications of centrifugal force and shearing stress response gene 1 in fatty liver and diabetes mellitus

A shear stress and fatty liver technology, applied in gene therapy, metabolic diseases, pharmaceutical formulations, etc., can solve problems such as increasing blood volume, affecting insulin function, and increasing the burden on the heart

Active Publication Date: 2014-08-27
武汉惠康达科技有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008]4) Insulin sensitizers work by activating PPAR-, and their biggest side effects are liver damage and increased blood volume, thus increasing

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Functions and applications of centrifugal force and shearing stress response gene 1 in fatty liver and diabetes mellitus
  • Functions and applications of centrifugal force and shearing stress response gene 1 in fatty liver and diabetes mellitus
  • Functions and applications of centrifugal force and shearing stress response gene 1 in fatty liver and diabetes mellitus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] [Example 1] Mouse fatty liver and diabetes model (DIO) obtained

[0051] 1. Grouping of experimental animals: 8-week-old, male, WT mice and RECS1KO mice were selected and fed with two special feeds, D12942 high-fat diet (Highfatdiet, HFD) and D12450B low-fat diet (Normalchow, NC), respectively, WTNC group, KONC group, WTHFD group, KOHFD group a total of 4 groups.

[0052] 2. Operation process of high-fat feed induction model:

[0053] Using WT and KO mice, the DIO model was established, and the phenotype correlation analysis was carried out to clarify that the RECS1 gene plays an important role in the pathogenesis of metabolic diseases. 8-week-old, male, WT mice and RECS1KO mice were selected and fed with two special diets, D12942 high-fat diet (Highfatdiet, HFD) and D12450B low-fat diet (Normalchow, NC), respectively, namely WTNC group, KONC group, WTHFD group, KOHFD group a total of 4 groups. The food intake of the mice was recorded in detail every week, and the fa...

Embodiment 2

[0054] [Example 2] Determination of body weight, blood sugar and insulin levels in fatty liver and diabetes model (DIO) mice

[0055] 1. Fasting body weight of mice, food intake detection, orbital sinus blood collection.

[0056] 1) Weight detection

[0057] ①Fasting: Fast the mice to be tested at 8:00 am (without water), and start the experimental operation at 2:00 pm.

[0058] ② Weighing: Weigh at 0 weeks, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, and 24 weeks, put a small plastic bucket on a dynamic electronic balance, grab the mouse, put it into the weighing In the small bucket, measure the body weight and record the data. Feed amount detection: After the weighing operation is completed, add feed to the mice, and record the amount of feed for the mice on the dynamic electronic balance.

[0059] 2) Blood was collected from the orbital sinus after ether inhalation anesthesia, and the serum was separated.

[0060] ① Anesthesia: Put the cotton ball dipped in ether in...

Embodiment 3

[0093] [Example 3] Glucose tolerance test (intraperitonealglucosettolerancetest, IPGTT)

[0094] On the 22nd week of the experiment, the intraperitoneal glucose injection test (IPGTT) was performed to evaluate the glucose tolerance of the mice.

[0095] ① Before measuring blood glucose, measure the fasting body weight of the mice, and calculate the injection volume of glucose based on 10 μL / g.

[0096] ② First test the fasting blood glucose at 0 minutes before the glucose injection, and inject the glucose solution through the abdominal cavity quickly after the test is completed.

[0097] ③Operation method of intraperitoneal injection: (1) Fix the mouse; grab the mouse, grasp the tail of the mouse with the little finger and ring finger of the left hand, and grasp the neck of the mouse with the other three fingers, so that the head of the mouse is downward, and the The abdomen of the mouse is fully exposed. (2) Needle positioning and injection: Insert the needle from the side ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses functions and applications of RECS1 in the fatty liver and the diabetes mellitus, and belongs to the field of functions and applications of genes. An RECS1 gene knockout mouse and a wild type C57 mouse are used as experimental subjects, through a model of the fatty liver and the diabetes mellitus which are induced by high-fat diets, the result shows that compared with the wild type C57 mouse, glycometabolism of the RECS1 gene knockout mouse is disorderly, fatty liver lesion is severe, and lipid accumulation is remarkably increased. It explains that the RECS1 has the adjustment and control capacity for maintaining the steady state of glycometabolism and has the liver lipid removal capacity and fatty liver forming resistance. Thus, the functions of the RECS1 in the fatty liver and the diabetes mellitus are found and the functions are mainly reflected in the effects on alleviating fatty liver and diabetes mellitus. For the functions of the RECS1, the RECS1 can be used for preparing medicine for treating the fatty liver and the diabetes mellitus.

Description

technical field [0001] The invention belongs to the field of gene function and application, and particularly relates to the function and application of a centrifugal force and shear stress response gene 1 (responsivetocentrifugalforceandshearstressgene1, RECS1) in fatty liver and diabetes. Background technique [0002] Diabetes is a chronic metabolic disease that seriously endangers human health. It is estimated that the number of patients will increase to 439 million by 2030, which means that 7.7% of adults aged 20-79 in the world will be diabetics. In the past two or three decades, the number of people with diabetes has doubled, and it is an extremely serious threat to human health around the world. At present, the incidence of type 2 diabetes and pre-type 2 diabetes among children, adolescents and young adults is increasing sharply, which also means that the incidence of diabetes will expand in the future, and the difficulty of prevention and treatment will increase great...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K48/00A61P1/16A61P3/10
Inventor 李红良赵光年汪涛杜成
Owner 武汉惠康达科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap